Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis
- PMID: 8308510
Penicillin failure and copathogenicity in streptococcal pharyngotonsillitis
Abstract
Recurrent group A beta-hemolytic streptococcus (GABHS) pharyngotonsillitis related to penicillin failure presents a serious clinical problem. Failure to eradicate streptococci from patients can occasionally lead to rheumatic fever and rarely to glomerulonephritis. beta-lactamase-producing strains of aerobic and anaerobic bacteria in inflamed tonsils have been associated with increased failure rates of penicillins in the eradication of these infections. These organisms include Staphylococcus aureus, Haemophilus influenzae and H parainfluenzae, Moraxella catarrhalis, Fusobacterium sp, and pigmented Prevotella and Porphyromonas spp. The indirect pathogenicity of these organisms is apparent in their ability not only to survive penicillin therapy but also to protect penicillin-susceptible pathogens from that drug. These organisms have demonstrated the ability to protect GABHS in vitro and in vivo from penicillin. Numerous reports have described the successful therapy of recurrent GABHS tonsillitis with antimicrobials directed at both GABHS and the beta-lactamase-producing organisms.
Similar articles
-
Overcoming penicillin failures in the treatment of Group A streptococcal pharyngo-tonsillitis.Int J Pediatr Otorhinolaryngol. 2007 Oct;71(10):1501-8. doi: 10.1016/j.ijporl.2007.06.006. Epub 2007 Jul 17. Int J Pediatr Otorhinolaryngol. 2007. PMID: 17644191 Review.
-
Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.Clin Ther. 2006 Jan;28(1):99-109. doi: 10.1016/j.clinthera.2006.01.006. Clin Ther. 2006. PMID: 16490583 Clinical Trial.
-
Controversies in the treatment of streptococcal pharyngitis.Am Fam Physician. 1990 Dec;42(6):1567-76. Am Fam Physician. 1990. PMID: 2244548
-
Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis.Arch Otolaryngol Head Neck Surg. 1995 Dec;121(12):1405-9. doi: 10.1001/archotol.1995.01890120061012. Arch Otolaryngol Head Neck Surg. 1995. PMID: 7488371
-
Failure of penicillin to eradicate group A beta-hemolytic streptococci tonsillitis: causes and management.J Otolaryngol. 2001 Dec;30(6):324-9. doi: 10.2310/7070.2001.19359. J Otolaryngol. 2001. PMID: 11771001 Review.
Cited by
-
Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection.Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5937-42. doi: 10.1073/pnas.0904831107. Epub 2010 Mar 15. Proc Natl Acad Sci U S A. 2010. PMID: 20231435 Free PMC article.
-
Biofilm formation by group a streptococci: is there a relationship with treatment failure?J Clin Microbiol. 2003 Sep;41(9):4043-8. doi: 10.1128/JCM.41.9.4043-4048.2003. J Clin Microbiol. 2003. PMID: 12958223 Free PMC article.
-
Etiology and Management of Acute and Recurrent Group A Streptococcal Tonsillitis.Curr Infect Dis Rep. 2001 Jun;3(3):217-223. doi: 10.1007/s11908-001-0023-6. Curr Infect Dis Rep. 2001. PMID: 11384551
-
Reconsidering sore throats. Part 2: Alternative approach and practical office tool.Can Fam Physician. 1997 Mar;43:495-500. Can Fam Physician. 1997. PMID: 9116521 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous